Last updated: 15 days ago
Moderna, Inc. Financial Report: Mixed Signals as of June 30, 2025
Explore Moderna's Q2 2025 financial report highlighting a net loss of $825M, cash decline, and deferred revenue growth. Investment recommendation: Hold.
Posts With Tag MRNA
Showing 1 - 6 of 6 Posts
Last updated: 15 days ago
Moderna, Inc. 8-K Report: Key Insights on August 1, 2025 Filing
Discover the latest 8-K filing by Moderna, Inc. (MRNA) on August 1, 2025. Learn about significant events impacting shareholders and stock performance.
Last updated: 4 months ago
Moderna, Inc. Q1 2025 Financial Report: Insights & Future Predictions
Explore Moderna's Q1 2025 financial performance, revealing key sales, losses, and strategic recommendations for investors amid evolving market dynamics.
Last updated: 4 months ago
Moderna, Inc. 8-K Filing: Key Insights and Corporate Updates
Explore the latest 8-K report for Moderna, Inc. detailing significant corporate events as of May 1, 2025. Learn about stock performance, SEC compliance, and more.
Last updated: 6 months ago
Moderna, Inc. 2024 Financial Report: Losses and Growth Potential Revealed
Explore Moderna, Inc.'s 2024 financial report highlighting $8.362B revenue, $3.607B loss, and R&D prospects. Investors advised to hold amid market challenges.
Last updated: 6 months ago
Moderna, Inc. 8-K Report: Key Updates & Insights as of February 14, 2025
Explore Moderna's latest 8-K report detailing significant developments. Discover insights on stock performance, regulatory compliance, and the biotech impact.